Suppression of Grb2 expression improved hepatic steatosis, oxidative stress, and apoptosis induced by palmitic acid in vitro partly through insulin signaling alteration

In Vitro Cellular and Developmental Biology - Animal

Volumn 49, Issue 8, 2013, Pages 576-582

  Shan, Xiangxiang ^a   Miao, Yufeng ^a   Fan, Rengen ^a   Song, Changzhi ^a   Wu, Guangzhou ^a   Wan, Zhengqiang ^a   Zhu, Jian ^a   Sun, Guan ^a   Zha, Wenzhang ^a   Mu, Xiangming ^a   Zhou, Guangjun ^a   Chen, Yan ^a  

^a Yancheng City No1 People's Hospital   (China)

Author keywords

Apoptosis; Grb2; HepG2; Insulin signaling; Steatosis

Indexed keywords

BAK1 PROTEIN, HUMAN; CASPASE 3; GRB2 PROTEIN, HUMAN; GROWTH FACTOR RECEPTOR BOUND PROTEIN 2; INSULIN; PALMITIC ACID; PROTEIN BAK;

APOPTOSIS; ARTICLE; CELL STRAIN HEPG2; CELL SURVIVAL; CHEMICALLY INDUCED DISORDER; DRUG EFFECT; FATTY LIVER; GENE EXPRESSION REGULATION; GENETICS; HUMAN; IN VITRO STUDY; LIPID METABOLISM; METABOLISM; OXIDATIVE STRESS; PATHOLOGY; PROTO ONCOGENE; SIGNAL TRANSDUCTION;

APOPTOSIS; BCL-2 HOMOLOGOUS ANTAGONIST-KILLER PROTEIN; CASPASE 3; CELL SURVIVAL; FATTY LIVER; GENE EXPRESSION REGULATION; GENES, BCL-2; GRB2 ADAPTOR PROTEIN; HEP G2 CELLS; HUMANS; INSULIN; LIPID METABOLISM; OXIDATIVE STRESS; PALMITIC ACID; SIGNAL TRANSDUCTION;

EID: 84890315754     PISSN: 10712690     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11626-013-9646-9     Document Type: Article

References (17)

1. Burks D. J.; White M. F. IRS proteins and beta-cell function. Diabetes 50(Suppl 1): S140-145; 2001.
2. Howard B. V. Insulin resistance and lipid metabolism. Am. J. Cardiol. 84: 28J-32J; 1999.
3. Johmura S.; Oh-hora M.; Inabe K.; Nishikawa Y.; Hayashi K.; Vigorito E.; Kitamura D.; Turner M.; Shingu K.; Hikida M.; Kurosaki T. Regulation of Vav localization in membrane rafts by adaptor molecules Grb2 and BLNK. Immunity 18: 777-787; 2003.
4. Kondo A.; Hirayama N.; Sugito Y.; Shono M.; Tanaka T.; Kitamura N. Coupling of Grb2 to Gab1 mediates hepatocyte growth factor-induced high intensity ERK signal required for inhibition of HepG2 hepatoma cell proliferation. J. Biol. Chem. 283: 1428-1436; 2008.
5. Langlais P.; Dong L. Q.; Ramos F. J.; Hu D.; Li Y.; Quon M. J.; Liu F. Negative regulation of insulin-stimulated mitogen-activated protein kinase signaling by Grb10. Mol. Endocrinol. 18: 350-358; 2004.
6. Leto D.; Saltiel A. R. Regulation of glucose transport by insulin: traffic control of GLUT4. Nat. Rev. Mol. Cell Biol. 13: 383-396; 2012.
7. Li J. W.; Wang G. P.; Fan J. Y.; Chang C. F.; Xu C. S. Eight paths of ERK1/2 signalling pathway regulating hepatocyte proliferation in rat liver regeneration. J. Genet. 90: 435-442; 2011.
8. Liu X.; Liu M.; Zhang J.; Bai X.; Ramos F.; Van Remmen H.; Richardson A.; Liu F. Y.; Dong L. Q.; Liu F. Downregulation of Grb2 contributes to the insulin-sensitizing effect of calorie restriction. Am. J. Physiol. Endocrinol. Metab. 296: E1067-E1075; 2009.
9. Malaguarnera M.; Di Rosa M.; Nicoletti F.; Malaguarnera L. Molecular mechanisms involved in NAFLD progression. J. Mol. Med. 87: 679-695; 2009.
10. Mao X.; Kikani C. K.; Riojas R. A.; Langlais P.; Wang L.; Ramos F. J.; Fang Q.; Christ-Roberts C. Y.; Hong J. Y.; Kim R. Y.; Liu F.; Dong L. Q. APPL1 binds to adiponectin receptors and mediates adiponectin signalling and function. Nat. Cell. Biol. 8: 516-523; 2006.
11. Mazza A.; Fruci B.; Garinis G. A.; Giuliano S.; Malaguarnera R.; Belfiore A. The role of metformin in the management of NAFLD. Exp. Diabetes. Res. 2012: 716404; 2012.
12. Samuel V. T.; Shulman G. I. Mechanisms for insulin resistance: common threads and missing links. Cell 148: 852-871; 2012.
13. Schlessinger J. Cell signaling by receptor tyrosine kinases. Cell 103: 211-225; 2000.
14. Sowers J. R. Insulin resistance and hypertension. Am. J. Physiol. Heart Circ. Physiol. 286: H1597-1602; 2004.
15. Smith B. W.; Adams L. A. Non-alcoholic fatty liver disease. Crit. Rev. Clin. Lab. Sci. 48: 97-113; 2011.
16. Tiikkainen M.; Häkkinen A. M.; Korsheninnikova E.; Nyman T.; Mäkimattila S.; Yki-Järvinen H. Effects of rosiglitazone and metformin on liver fat content, hepatic insulin resistance, insulin clearance, and gene expression in adipose tissue in patients with type 2 diabetes. Diabetes 53: 2169-2176; 2004.
17. Wieckowska A.; Zein N. N.; Yerian L. M.; Lopez A. R.; McCullough A. J.; Feldstein A. E. In vivo assessment of liver cell apoptosis as a novel biomarker of disease severity in nonalcoholic fatty liver disease. Hepatology 44: 27-33; 2006.